title: Does acute occlusion of the carotid T invariably have a poor outcome?
authors.forename: Y
authors.initials: Y
authors.lastname: Samson
authors.forename: S
authors.initials: S
authors.lastname: Crozier
authors.forename: S
authors.initials: S
authors.lastname: Deltour
authors.forename: M
authors.initials: M
authors.lastname: Obadia
authors.forename: M
authors.initials: M
authors.lastname: Bruandet
authors.forename: A
authors.initials: A
authors.lastname: Leger
mesh_terms: D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000368:Aged; D002341:Carotid Artery Thrombosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000401:mortality; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D008875:Middle Aged; D020521:Stroke / Q000401:mortality / Q000517:prevention & control / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator